(Q46807392)

English

Using translational research to tailor the use of chemotherapy in the treatment of NSCLC.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16291424

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16291424

title

Using translational research to tailor the use of chemotherapy in the treatment of NSCLC. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16291424

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16291424

1 reference

Gerold Bepler

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16291424

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16291424

publication date

1 October 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16291424

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16291424

published in

Lung Cancer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16291424

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16291424

volume

50 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16291424

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16291424

page(s)

S13-4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16291424

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16291424

cites work

Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0169-5002%2805%2981553-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0169-5002%2805%2981553-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0169-5002%2805%2981553-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0169-5002(05)81553-3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16291424

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16291424

PubMed publication ID

16291424

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16291424

retrieved

25 December 2017

reference URL

http://europepmc.org/abstract/MED/16291424

(Q46807392)

Using translational research to tailor the use of chemotherapy in the treatment of NSCLC.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)